Anti-PD-1 immunotherapy – Pembrolizumab current clinical trials for advanced head and neck cancer: A mapping systematic study. (January 2023) - Manzoor, Humayun; Rasheed, Amina; Zeen, Farah; Sarfraz, Azza; Sarfraz, Zouina